Voyager Therapeutics (VYGR) Free Cash Flow Growth (1y) (2015 - 2026)
Powered by 
Analysis
Voyager Therapeutics (VYGR) Free Cash Flow Growth (1y) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 40.14% |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | 11.55% |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | -235.00% |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | -14.39% |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 17,755.56% |
| 10 | Voyager Therapeutics | 195.27 Mn | 78.93 Mn | - | 24.22% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.22% |
| Mar 31, 2026 | 13.28% |
| Dec 31, 2025 | -110.36% |
| Sep 30, 2025 | -10.73% |
| Jun 30, 2025 | -5.59% |
| Mar 31, 2025 | -168.08% |
| Dec 31, 2024 | 40.10% |
| Sep 30, 2024 | -29.28% |
| Jun 30, 2024 | -1,491.54% |
| Mar 31, 2024 | -53.98% |
| Dec 31, 2023 | -86.04% |
| Sep 30, 2023 | -32.45% |
| Jun 30, 2023 | 89.53% |
| Mar 31, 2023 | 259.83% |
| Dec 31, 2022 | -221.47% |
| Sep 30, 2022 | 22.86% |
| Jun 30, 2022 | 14.85% |
| Mar 31, 2022 | 257.82% |
| Dec 31, 2021 | 142.49% |
| Sep 30, 2021 | 28.51% |